Advertisement

WITHDRAWN: Dual Therapy With Infliximab and Immunomodulator Reduces 1-Year Rates of Hospitalization and Surgery Among Veterans With Inflammatory Bowel Disease

  • NEENA S. ABRAHAM
    Affiliations
    Section of Digestive Diseases

    Houston VA Health Services Research and Development Center of Excellence, Michael E. DeBakey Veterans Affairs Medical Center, Division of Gastroenterology and Hepatology, Baylor College of Medicine, Houston, Texas
    Search for articles by this author
  • PETER RICHARDSON
    Affiliations
    Houston VA Health Services Research and Development Center of Excellence, Michael E. DeBakey Veterans Affairs Medical Center, Division of Gastroenterology and Hepatology, Baylor College of Medicine, Houston, Texas
    Search for articles by this author
  • DIANA CASTILLO
    Affiliations
    Houston VA Health Services Research and Development Center of Excellence, Michael E. DeBakey Veterans Affairs Medical Center, Division of Gastroenterology and Hepatology, Baylor College of Medicine, Houston, Texas
    Search for articles by this author
  • SUNANDA KANE
    Affiliations
    Division of Gastroenterology, Mayo Clinic School of Medicine, Rochester, Minnesota
    Search for articles by this author
      This paper is only available as a PDF. To read, Please Download here.
      The Publisher regrets that this article is an accidental duplication of an article that has already been published, http://dx.doi.org/10.1016/j.cgh.2013.06.004.
      The duplicate article has therefore been withdrawn.
      To read this article in full you will need to make a payment
      AGA Member Login
      Login with your AGA username and password.

      Purchase one-time access:

      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect